Display options
Cite
Yan M, Li J, He N, et al. A case-control study of the association between the . Oncotarget. 2017;8(35):59823-59830doi: 10.18632/oncotarget.16946.
Yan, M., Li, J., He, N., Shi, X., Du, S., Li, B., & Jin, T. (2017). A case-control study of the association between the . Oncotarget, 8(35), 59823-59830. https://doi.org/10.18632/oncotarget.16946
Yan, Mengdan, et al. "A case-control study of the association between the ." Oncotarget vol. 8,35 (2017): 59823-59830. doi: https://doi.org/10.18632/oncotarget.16946
Yan M, Li J, He N, Shi X, Du S, Li B, Jin T. A case-control study of the association between the . Oncotarget. 2017 Apr 07;8(35):59823-59830. doi: 10.18632/oncotarget.16946. eCollection 2017 Aug 29. PMID: 28938685; PMCID: PMC5601781.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Apr 07;8(35):59823-59830. doi: 10.18632/oncotarget.16946. eCollection 2017 Aug 29.

A case-control study of the association between the .

Oncotarget

Mengdan Yan, Jingjie Li, Na He, Xugang Shi, Shuli Du, Bin Li, Tianbo Jin

Affiliations

  1. Key Laboratory of Resource Biology and Biotechnology in Western China, Northwest University, Ministry of Education, Xi'an, China.
  2. Xi'an Tiangen Precision Medical Research Institute, Xi'an, China.
  3. Department of Neurosurgery, Xi'an First Hospital, Xi'an, China.

PMID: 28938685 PMCID: PMC5601781 DOI: 10.18632/oncotarget.16946

Abstract

The Epidermal Growth Factor Receptor gene has been reported to be involved in the progression of gliomas which is one of the deadliest primary brain tumors in humans. To determine potential association between

Keywords: EGFR gene; case–control study; glioma; tag single nucleotide polymorphism

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no competing financial interests.

References

  1. J Urol. 2010 May;183(5):2062-9 - PubMed
  2. Bioinformatics. 2006 Aug 1;22(15):1928-9 - PubMed
  3. Int J Mol Epidemiol Genet. 2013 Nov 28;4(4):235-49 - PubMed
  4. Genet Test Mol Biomarkers. 2015 Jan;19(1):59-62 - PubMed
  5. Acta Oncol. 2010 Aug;49(6):767-75 - PubMed
  6. Acta Neuropathol. 2004 Aug;108(2):135-42 - PubMed
  7. Neuro Oncol. 2012 Nov;14 Suppl 5:v1-49 - PubMed
  8. Cancer Sci. 2009 Dec;100(12):2235-41 - PubMed
  9. J Neuropathol Exp Neurol. 2005 Jun;64(6):479-89 - PubMed
  10. Cancer Res. 2006 Apr 15;66(8):4531-41 - PubMed
  11. Cancer Res. 2004 Oct 1;64(19):6892-9 - PubMed
  12. Acta Neuropathol. 2007 Aug;114(2):97-109 - PubMed
  13. Asian Pac J Cancer Prev. 2012;13(10):4905-8 - PubMed
  14. Nat Genet. 2007 Mar;39(3):347-51 - PubMed
  15. Cell Res. 2005 Feb;15(2):97-8 - PubMed
  16. BMJ. 2000 May 27;320(7247):1468 - PubMed
  17. J Hered. 1995 Sep-Oct;86(5):409-11 - PubMed
  18. Curr Protoc Hum Genet. 2009 Jan;Chapter 2:Unit 2.12 - PubMed
  19. PLoS One. 2012;7(5):e37531 - PubMed
  20. Cancer Res. 1996 Nov 1;56(21):5079-86 - PubMed
  21. J Cancer Res Clin Oncol. 2009 Feb;135(2):313-8 - PubMed
  22. Acta Neuropathol. 2005 Jan;109(1):93-108 - PubMed

Publication Types